The C718T polymorphism in the 3′-untranslated region of glutathione peroxidase-4 gene is a predictor of cerebral stroke in patients with essential hypertension

Hypertension Research

Volumn 35, Issue 5, 2012, Pages 507-512

  Polonikov, Alexey V ^a   Vialykh, Ekaterina K ^b   Churnosov, Mikhail I ^c   Illig, Thomas ^d   Freidin, Maxim B ^e   Vasil'Eva, Oksana V ^a   Bushueva, Olga Yu ^a   Ryzhaeva, Valentina N ^a   Bulgakova, Irina V ^a   Solodilova, Maria A ^a  

^a KURSK STATE MEDICAL UNIVERSITY   (Russian Federation)

^b Kursk Regional Clinical Hospital   (Russian Federation)

^c BELGOROD STATE UNIVERSITY   (Russian Federation)

^d INSTITUTE OF EPIDEMIOLOGY   (Germany)

^e RESEARCH INSTITUTE OF MEDICAL GENETICS   (Russian Federation)

Author keywords

Cerebral stroke; Essential hypertension; Genetic susceptibility to disease; Glutathione peroxidase genes; Single nucleotide polymorphism

Indexed keywords

ANTIHYPERTENSIVE AGENT; GLUTATHIONE PEROXIDASE 1; GLUTATHIONE PEROXIDASE 3; PHOSPHOLIPID HYDROPEROXIDE GLUTATHIONE PEROXIDASE;

3' UNTRANSLATED REGION; ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; BODY MASS; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ESSENTIAL HYPERTENSION; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTOLIC BLOOD PRESSURE;

3' UNTRANSLATED REGIONS; AGED; ANTIHYPERTENSIVE AGENTS; FEMALE; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GLUTATHIONE PEROXIDASE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; PREVALENCE; RISK; STROKE;

EID: 84860721060     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1038/hr.2011.213     Document Type: Article

References (35)

1. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo Jr JL, Jones DW, Materson BJ, Oparil S, Wright Jr JT, Roccella EJ. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289: 2560-2572.
2. Goldstein LB, Bushnell CD, Adams RJ, Appel LJ, Braun LT, Chaturvedi S, Creager MA, Culebras A, Eckel RH, Hart RG, Hinchey JA, Howard VJ, Jauch EC, Levine SR, Meschia JF, Moore WS, Nixon JV, Pearson TA. Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2011; 42: 517-584.
3. Sugawara T, Chan PH. Reactive oxygen radicals and pathogenesis of neuronal death after cerebral ischemia. Antioxid Redox Signal 2003; 5: 597-607.
4. Zimmermann C, Winnefeld K, Streck S, Roskos M, Haberl RL. Antioxidant status in acute stroke patients and patients at stroke risk. Eur Neurol 2004; 51: 157-161.
5. Aygul R, Kotan D, Demirbas F, Ulvi H, Deniz O. Plasma oxidants and antioxidants in acute ischaemic stroke. J Int Med Res 2006; 34: 413-418.
6. Rodrigo R, Prat H, Passalacqua W, Araya J, Guichard C, Bächler JP. Relationship between oxidative stress and essential hypertension. Hypertens Res 2007; 30: 1159-1167.
7. Amantea D, Marrone MC, Nisticò R, Federici M, Bagetta G, Bernardi G, Mercuri NB. Oxidative stress in stroke pathophysiology validation of hydrogen peroxide metabolism as a pharmacological target to afford neuroprotection. Int Rev Neurobiol 2009; 85: 363-374.
8. Nanetti L, Raffaelli F, Vignini A, Perozzi C, Silvestrini M, Bartolini M, Provinciali L, Mazzanti L. Oxidative stress in ischaemic stroke. Eur J Clin Invest 2011; 41: 1318-1322.
9. Forsberg L, de Faire U, Marklund SL, Andersson PM, Stegmayr B, Morgenstern R. Phenotype determination of a common Pro-Leu polymorphism in human glutathione peroxidase 1. Blood Cells Mol Dis 2000; 26: 423-426.
10. Voetsch B, Jin RC, Bierl C, Benke KS, Kenet G, Simioni P, Ottaviano F, Damasceno BP, Annichino-Bizacchi JM, Handy DE, Loscalzo J. Promoter polymorphisms in the plasma glutathione peroxidase (GPx-3) gene: a novel risk factor for arterial ischemic stroke among young adults and children. Stroke 2007; 38: 41-49.
11. Voetsch B, Jin RC, Bierl C, Deus-Silva L, Camargo EC, Annichino-Bizacchi JM, Handy DE, Loscalzo J. Role of promoter polymorphisms in the plasma glutathione peroxidase (GPx-3) gene as a risk factor for cerebral venous thrombosis. Stroke 2008; 39: 303-307.
12. Grond-Ginsbach C, Lichy C, Padovani A, Pezzini A. GPx-3 gene promoter variation and the risk of arterial ischemic stroke. Stroke 2007; 38: e23.
13. Polonikov AV, Ivanov VP, Solodilova MA, Khoroshaya IV, Kozhuhov MA, Ivakin VE, Katargina LN, Kolesnikova OE. A common polymorphism G-50T in cytochrome P450 2J2 gene is associated with increased risk of essential hypertension in a Russian population. Dis Markers 2008; 24: 119-126.
14. Hu YJ, Diamond AM. Role of glutathione peroxidase 1 in breast cancer: loss of heterozygosity and allelic differences in the response to selenium. Cancer Res 2003; 63: 3347-3351.
15. Méplan C, Crosley LK, Nicol F, Horgan GW, Mathers JC, Arthur JR, Hesketh JE. Functional effects of a common single-nucleotide polymorphism (GPX4c718t) in the glutathione peroxidase 4 gene: interaction with sex. Am J Clin Nutr 2008; 87: 1019-1027.
16. Foresta C, Flohe L, Garolla A, Roveri A, Ursini F, Maiorino M. Male fertility is linked to the selenoprotein phospholipid hydroperoxide glutathione peroxidase. Biol Reprod 2002; 67: 967-971.
17. Villette S, Kyle JA, Brown KM, Pickard K, Milne JS, Nicol F, Arthur JR, Hesketh JE. A novel single nucleotide polymorphism in the 3¢ untranslated region of human glutathione peroxidase 4 influences lipoxygenase metabolism. Blood Cells Mol Dis 2002; 29: 174-178.
18. Diaconu M, Tangat Y, Bohm D, Kühn H, Michelmann HW, Schreiber G, Haidl G, Glander HJ, Engel W, Nayernia K. Failure of phospholipid hydroperoxide glutathione peroxidase expression in oligoasthenozoospermia and mutations in the PHGPx gene. Andrologia 2006; 38: 152-157.
19. Bermano G, Pagmantidis V, Holloway N, Kadri S, Mowat NA, Shiel RS, Arthur JR, Mathers JC, Daly AK, Broom J, Hesketh JE. Evidence that a polymorphism within the 3¢UTR of glutathione peroxidase 4 is functional and associated with susceptibility to colorectal cancer. Genes Nutr 2007; 2: 225-232.
20. Foster CB, Aswath K, Chanock SJ, McKay HF, Peters U. Polymorphism analysis of six selenoprotein genes: support for a selective sweep at the glutathione peroxidase 1 locus (3p21) in Asian populations. BMC Genet 2006; 7: 56.
21. Udler M, Maia AT, Cebrian A, Brown C, Greenberg D, Shah M, Caldas C, Dunning A, Easton D, Ponder B, Pharoah P. Common germline genetic variation in antioxidant defense genes and survival after diagnosis of breast cancer. J Clin Oncol 2007; 25: 3015-3023.
22. Koyama H, Abdulah R, Ohkubo T, Imai Y, Satoh H, Nagai K. Depressed serum selenoprotein P: possible new predicator of increased risk for cerebrovascular events. Nutr Res 2009; 29: 94-99.
23. Gautrey H, Nicol F, Sneddon AA, Hall J, Hesketh J. A T/C polymorphism in the GPX4 3¢UTR affects the selenoprotein expression pattern and cell viability in transfected Caco-2 cells. Biochim Biophys Acta 2011; 1810: 284-291.
24. Berry MJ. Insights into the hierarchy of selenium incorporation. Nat Genet 2005; 37: 1162-1163.
25. Wingler K, Bocher M, Flohe L, Kollmus H, Brigelius-Flohe R. mRNA stability and selenocysteine insertion sequence efficiency rank gastrointestinal glutathione peroxidase high in the hierarchy of selenoproteins. Eur J Biochem 1999; 259: 149-157.
26. Nakase T, Yamazaki T, Ogura N, Suzuki A, Nagata K. The impact of inflammation on the pathogenesis and prognosis of ischemic stroke. J Neurol Sci 2008; 271: 104-109.
27. Ishibashi N, Prokopenko O, Weisbrot-Lefkowitz M, Reuhl KR, Mirochnitchenko O. Glutathione peroxidase inhibits cell death and glial activation following experimental stroke. Brain Res Mol Brain Res 2002; 109: 34-44.
28. Jin RC, Mahoney CE, Coleman Anderson L, Ottaviano F, Croce K, Leopold JA, Zhang YY, Tang SS, Handy DE, Loscalzo J. Glutathione peroxidase-3 deficiency promotes plateletdependent thrombosis in vivo. Circulation 2011; 123: 1963-1973.
29. Nowak-Gö ttl U, Fiedler B, Huge A, Niederstadt T, Thedieck S, Seehafer T, Stoll M. Plasma glutathione peroxidase in pediatric stroke families. J Thromb Haemost 2011; 9: 33-38.
30. Wong CH, Bozinovski S, Hertzog PJ, Hickey MJ, Crack PJ. Absence of glutathione peroxidase-1 exacerbates cerebral ischemia-reperfusion injury by reducing postischemic microvascular perfusion. J Neurochem 2008; 107: 241-252.
31. Takizawa S, Matsushima K, Shinohara Y, Ogawa S, Komatsu N, Utsunomiya H, Watanabe K. Immunohistochemical localization of glutathione peroxidase in infarcted human brain. J Neurol Sci 1994; 122: 66-73.
32. Hoehn B, Yenari MA, Sapolsky RM, Steinberg GK. Glutathione peroxidase overexpression inhibits cytochrome C release and proapoptotic mediators to protect neurons from experimental stroke. Stroke 2003; 34: 2489-2494.
33. Weisbrot-Lefkowitz M, Reuhl K, Perry B, Chan PH, Inouye M, Mirochnitchenko O. Overexpression of human glutathione peroxidase protects transgenic mice against focal cerebral ischemia/reperfusion damage. Brain Res Mol Brain Res 1998; 53: 333-338.
34. Avshalumov MV, Rice ME. Activation of ATP-sensitive K+ (K(ATP)) channels by H2O2 underlies glutamate-dependent inhibition of striatal dopamine release. Proc Natl Acad Sci USA 2003; 100: 11729-11734.
35. 2 is a novel, endogenous modulator of synaptic dopamine release. J Neurophysiol 2001; 85: 2468-2476.